Enfermedades olvidadas no son business para laboratorios pero matan a miles cada año

Publicado en por Ivonne Leites. - Atea y sublevada.

 

 

 

 

SALUD. SE TRATAN CON MEDICAMENTOS DE HACE MÁS DE UN SIGLO

Enfermedades olvidadas matan a miles cada año

Según experto, farmacéuticas no tienen incentivos para atender el tema

Martes 26 de Abril del 2011

 

NSTER, ALEMANIA [DPA]. Cada año mueren más de 100.000 personas en todo el mundo a causa de enfermedades olvidadas por la industria farmacéutica y la investigación médica, recordó el experto Thomas Schmidt, en entrevista con DPA.

Casi todas esas enfermedades se registran en los trópicos o subtrópicos o “en los hogares más pobres de este mundo” y el alarmante aumento de la población en las grandes ciudades de Latinoamérica, Asia y África no hace más que agravar el problema, recordó el farmacéutico e investigador de plantas medicinales en la Universidad de Münster.

“La industria farmacéutica no tiene ningún incentivo económico porque esas enfermedades no suelen manifestarse en el mundo industrializado. En la opinión pública se escucha muy poco sobre ello. Todos conocen la diabetes, pero pregunten a la gente si sabe algo de la tripanosomiasis humana africana, de la leishmaniasis o la enfermedad de Chagas”, subrayó Schmidt.

En su opinión, lo peor de todo no es que los médicos sepan poco del tema, sino que “la industria farmacéutica se ocupe mucho menos de ellas que del resto de males”.

Según citó, solo tres de las 13 enfermedades consideradas descuidadas u olvidadas causan la muerte de unas 110.000 personas al año. Para tratarlas, los únicos medicamentos son prácticamente los mismos hechos por los colonizadores hace más de un siglo para sanar a su población. “Y siguen siendo los únicos eficaces”, indicó.

SEPA MÁS
Algunos esfuerzos
Bayer invierte 25 millones de euros en dos proyectos sobre enfermedades olvidadas, cada uno de ellos a cinco años. Sanofi-Aventis y GlaxoSmith-Kline están empezando a negociar presupuestos.

Seminal ...Formato de archivo: PDF/Adobe Acrobat - Vista rápida
Dr. Thomas J. Schmidt, Institut für Pharmazeutische Biologie und Phytochemie ... suburban population that suffers from diseases such as Chagas' Disease and ...
www.dbwti.de/.../Seminal%20Workshop_NaturalProductsAgainstNeglectedDiseases_Brazil_Germany_short_260111...

Natural Products against Neglected Diseases Dates, Times, LocationFormato de archivo: PDF/Adobe Acrobat - Vista rápida
Chagas-disease, Leishmaniasis and further protozoan infections. This seminal meeting hosted by the ... Thomas J. Schmidt: University of Münster, Germany ...
www.uni-muenster.de/.../symposiumneglecteddiseases/flyer_workshop_npnd.pdf

 

.www.stanford.edu/.../Leishmaniasis/cutaneous.htm

 





 

.www.stanford.edu/.../Leishmaniasis/cutaneous.htm

.





Seminal Workshop „ Brasilian-German Research Initiative on

Natural Products against Neglected

Diseases

Date: April 26 -29, 2011

Brazil is among the countries most strongly haunted by parasitic diseases caused by protozoan pathogens.

These infections severely affect the country’s public health and welfare. It is mainly the poor rural and

suburban population that suffers from diseases such as Chagas’ Disease and Leishmanioses. The former, e.g., is an acute threat for approximately 35 Millions of people with an estimated 600.000 new infections and 11.000

deaths per year world-wide, children being most frequently affected. Big pharmaceutical companies are still

not investing duly into the development of new safe and efficacious remedies. However, in the last decade,

non-profit research initiatives such as DNDi have brought new progress to this field. Not being able to develop

new therapeuticals from drug discovery to an approved medication on its own, academic research can yet play

an important role in this endeavor by performing basic research in the pre-clinical phases, i.e. discovery of new

active compounds, elucidation of new mechanisms and setup of new strategies by which the parasites may be

attacked. One important source in the search for new antiprotozoal compounds is nature itself.

 

Many highly

active natural products have been used in medicine, including treatment of protozoan infections such as

Malaria, for many centuries. Natural products are being investigated by many research groups also for their

 

 

 

 

Trypanosoma cruzi and various Leishmania  species, respectively).

 

The main

objective of the planned event is to bring together scientists from Brazil and Germany who are already working

in this field and intending to dedicate more of their research towards this endeavor. Natural Products Chemists

/ Medicinal plant researchers from both countries will meet biomedical and medical scientists working in the

fields of antiprotozoal testing as well as officials and researchers from non-profit organizations involved in the

development of new antiprotozoal therapies and field clinical studies.

 

Bringing together the right people with a broad spectrum of viewpoints focused on one common aim will

enable discussions between researchers working on the various aspects along the drug development line. The

meeting will be the starting point for new antiprotozoal research projects, and will thus initiate a truly

coordinated and focused multilateral effort towards this important goal.

 

The meeting will take place at the Westfälische Wilhelms-Universität Münster, where it will be held at the

Münster Castle (the main University building and seat of the Rectorate) in a suitable atmosphere for fruitful

scientific discussions and the making of future plans. The meeting will proceed over three days and consist of a

series of plenary and short lectures on the various relevant aspects, each followed by a sufficient amount of

time for thorough discussions, accompanied by “brainstorming sessions” as well as sufficient amount of time

for discussions in smaller groups and summarizing plenary discussions on each day. As a final outcome, a

proceedings book will be issued along with a common agenda and a declaration of aims and goals for the

planned initiative.

 

 

http://www.smh.de/i/content/Thomas_Schmidt.jpg

 

http://www.dbwti.de/veranstaltungskalender/app/webroot/files/104/Seminal%20Workshop_NaturalProductsAgainstNeglectedDiseases_Brazil_Germany_short_260111.pdf

 

 

[PDF]

Natural Products as Antiprotozoal Leads – In-vitro and In-Silico ...Formato de archivo: PDF/Adobe Acrobat - Vista rápida
de TJ Schmidt - Artículos relacionados
Thomas J. Schmidt. Institut für Pharmazeutische Biologie und Phytochemie, Westfälische Wilhelms-Universität Münster – Münster,. Germany ...
www.uni-muenster.de/imperia/md/content/.../abstract_schmidt.pdf



Workshop Iniciativa de Pesquisas Brasil-Alemanha sobre Produtos ... - [ Traducir esta página ]

Contato: Westfälische Wilhelms-Universität Münster Prof. Dr. Thomas J. Schmidt. thomschm@uni-muenster.de. Parceiro do Projeto: ...
www.dbwti.de/br/209.php?id=213&lang=pt-br& - En caché
.
.



Etiquetado en Salud y Medio Ambiente

Comentar este post